Picture of Gerresheimer AG logo

GXI Gerresheimer AG Share Price

0.000.00%
de flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Momentum

Relative Strength (%)
1m-5.03%
3m+3.74%
6m-10.34%
1yr+5.75%
Volume Change (%)
10d/3m+6.31%
Price vs... (%)
52w High-19.53%
50d MA-2.78%
200d MA-1.08%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)17.89
PEG Ratio (f)0.76
EPS Growth (f)30.57%
Dividend Yield (f)1.44%
Valuation (ttm)IndustryMarket
Price to Book Value2.38
Price to Tang. Book19.04
Price to Free Cashflown/a
Price to Sales1.71
EV to EBITDA11.01

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital8.58%
Return on Equity9.02%
Operating Margin10.72%

Financial Summary

Year End 30th NovUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€m1,392.261,418.791,498.011,817.091,990.492,130.772,385.497.79%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-7.74+21.21-6.2+21+8.13+33.2+27.48n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Nov 202430th Nov 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Gerresheimer AG EPS forecast chart

Profile Summary

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.

Directors

Last Annual
November 30th, 2023
Last Interim
February 29th, 2024
Incorporated
April 4th, 2007
Public Since
June 11th, 2007
No. of Employees
11,947
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
de flag iconXETRA
Shares in Issue
34,540,000

GXI Share Price Performance

Upcoming Events for GXI

Gerresheimer AG Annual Shareholders Meeting

Dividend For GXIG.DE - 1.2500 EUR

Gerresheimer AG Annual Shareholders Meeting

Q2 2024 Gerresheimer AG Earnings Release

Q3 2024 Gerresheimer AG Earnings Release

FAQ